EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • May 3rd, 2023 • Glycomimetics Inc • Pharmaceutical preparations • Maryland
Contract Type FiledMay 3rd, 2023 Company Industry JurisdictionThis Executive Employment Agreement (the “Agreement”) is entered into effective February 10, 2023 (the “Effective Date”), by and between Chinmaya Rath and GlycoMimetics, Inc. (the “Company”).
Re:Transition Agreement Dear John: This letter sets forth the substance of the Transition Agreement (the “Transition Agreement” or “Agreement”) which GlycoMimetics, Inc. (the “Company”) is offering to you.Transition Agreement • May 3rd, 2023 • Glycomimetics Inc • Pharmaceutical preparations • Maryland
Contract Type FiledMay 3rd, 2023 Company Industry Jurisdiction
Consulting AgreementConsulting Agreement • May 3rd, 2023 • Glycomimetics Inc • Pharmaceutical preparations • Maryland
Contract Type FiledMay 3rd, 2023 Company Industry JurisdictionThis Consulting Agreement (the “Agreement”) by and between GlycoMimetics, Inc. (“Client”) and John Magnani, Ph.D., an individual (“Consultant”) is effective as of March 31, 2023 (the “Effective Date”).
Release AgreementRelease Agreement • May 3rd, 2023 • Glycomimetics Inc • Pharmaceutical preparations
Contract Type FiledMay 3rd, 2023 Company IndustryThis Release Agreement (“Release”) is made by and between GlycoMimetics, Inc. (the “Company”) and Armand Girard (“you”). You and the Company entered into an Amended and Restated Employment Agreement dated July 30, 2019 (the “Employment Agreement”). You and the Company hereby further agree as follows: